Pro-Dex (NASDAQ:PDEX) Getting Somewhat Negative News Coverage, Report Finds

Headlines about Pro-Dex (NASDAQ:PDEX) have been trending somewhat negative on Saturday, Accern reports. Accern identifies negative and positive press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Pro-Dex earned a news sentiment score of -0.01 on Accern’s scale. Accern also gave news coverage about the medical instruments supplier an impact score of 47.1875189031792 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Separately, Ascendiant Capital Markets reissued a “buy” rating and set a $9.00 target price (up previously from $8.00) on shares of Pro-Dex in a research report on Friday, September 8th.

Pro-Dex (NASDAQ:PDEX) traded up 4.20% during mid-day trading on Friday, reaching $7.45. 21,204 shares of the company were exchanged. The stock’s 50-day moving average is $6.63 and its 200-day moving average is $5.65. Pro-Dex has a 12 month low of $3.80 and a 12 month high of $7.90. The company has a market cap of $29.99 million, a P/E ratio of 5.96 and a beta of -0.42.

TRADEMARK VIOLATION NOTICE: “Pro-Dex (NASDAQ:PDEX) Getting Somewhat Negative News Coverage, Report Finds” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://ledgergazette.com/2017/09/17/pro-dex-pdex-getting-somewhat-critical-media-coverage-study-finds.html.

About Pro-Dex

Pro-Dex, Inc (Pro-Dex) designs and produces surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Company operates through four segments: Pro-Dex, OMS, Fineline and Engineering Services Division (ESD). The Pro-Dex segment provides primarily medical and dental instruments using shared production and assembly machines and workforce.

Insider Buying and Selling by Quarter for Pro-Dex (NASDAQ:PDEX)

Receive News & Ratings for Pro-Dex Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply